In early 2020, Memphis-based SOMAVAC Medical Solutions Inc. was off to a fast start. The startup, which has an FDA-approved, modern surgical drain pump device, hired a VP of sales, John Flynn, in January.
When Joe Prude called Rochester, New York, police to report his brother missing, he was struggling to understand why Daniel Prude had been released from the hospital hours earlier. Joe Prude described his brother’s suicidal behavior.
For Dr. Amber Thacker, going into medicine was more or less second nature. As a kid, she would buy old medical and science textbooks. She set up a lab in her closet.
The University of Tennessee Health Science Center and Regional One Health are partnering on a clinical trial program in Memphis to evaluate a drug for COVID-19 treatment. The Memphis medical college and hospital announced Thursday they will provide late-stage trials for Regeneron’s REGN-COV2, an antibody cocktail the company is investigating for possible treatment and prevention… Read More
If a COVID-19 vaccine is widely available in the nation even by next spring, it could be months — even after the start of school next fall — before it’s available for children. The good news is children so far are less affected by the virus. The bad news? If children aren’t vaccinated, they can spread the… Read More
Salvatore Mancarella, PhD, associate professor in the Department of Physiology in the College of Medicine at the University of Tennessee Health Science Center, was recently awarded $1.52 million from the National Institutes of Health (NIH) to support his investigations into the molecular-level causes of cardiac muscle deterioration. Also: BioEngineer
In an opinion article published in Frontiers in Pediatrics, Dr. Arun Saini — an assistant professor in the Division of Critical Care Medicine at the University of Tennessee Health Science Center in Memphis — describes the reasons for physicians seeking a better work-life balance as varied and personal. “Dissatisfaction, depression, and burnout are common in… Read More
Now is the time to prepare for the availability of a safe and effective COVID-19 vaccine, particularly since currently only 65 percent of Americans report they will be willing to get a FDA-approved vaccine provided at no cost. A vaccine will be an essential component to fully reopening schools and businesses and getting back to… Read More
